Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SBC Medical Group Holdings (SBCWW) Net Income towards Common Stockholders (2023 - 2025)

Historic Net Income towards Common Stockholders for SBC Medical Group Holdings (SBCWW) over the last 3 years, with Q3 2025 value amounting to $12.8 million.

  • SBC Medical Group Holdings' Net Income towards Common Stockholders rose 35275.98% to $12.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.1 million, marking a year-over-year decrease of 798.86%. This contributed to the annual value of $32.3 million for FY2024, which is 1630.63% down from last year.
  • As of Q3 2025, SBC Medical Group Holdings' Net Income towards Common Stockholders stood at $12.8 million, which was up 35275.98% from $2.4 million recorded in Q2 2025.
  • Over the past 5 years, SBC Medical Group Holdings' Net Income towards Common Stockholders peaked at $21.5 million during Q1 2025, and registered a low of -$5.7 million during Q4 2024.
  • Its 3-year average for Net Income towards Common Stockholders is $6.7 million, with a median of $2.8 million in 2024.
  • Data for SBC Medical Group Holdings' Net Income towards Common Stockholders shows a peak YoY increase of 782494.33% (in 2024) and a maximum YoY decrease of 15894.55% (in 2024) over the last 5 years.
  • Over the past 3 years, SBC Medical Group Holdings' Net Income towards Common Stockholders (Quarter) stood at $15.6 million in 2023, then crashed by 136.61% to -$5.7 million in 2024, then surged by 324.58% to $12.8 million in 2025.
  • Its Net Income towards Common Stockholders was $12.8 million in Q3 2025, compared to $2.4 million in Q2 2025 and $21.5 million in Q1 2025.